More accountability needed in how drugs are priced and reimbursed

Piotr Ozieranski, Lawrence King

Research output: Contribution to specialist publicationArticle

Original languageEnglish
Specialist publicationThe Conversation
PublisherThe Conversation
Publication statusPublished - 23 May 2016

Cite this